BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 17003096)

  • 1. Sleep-related breathing disorders in prepubertal children with Prader-Willi syndrome and effects of growth hormone treatment.
    Festen DA; de Weerd AW; van den Bossche RA; Joosten K; Hoeve H; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2006 Dec; 91(12):4911-5. PubMed ID: 17003096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term effects of growth hormone on sleep abnormalities in Prader-Willi syndrome.
    Miller J; Silverstein J; Shuster J; Driscoll DJ; Wagner M
    J Clin Endocrinol Metab; 2006 Feb; 91(2):413-7. PubMed ID: 16317059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Growth Hormone Treatment on Sleep-Related Parameters in Adults With Prader-Willi Syndrome.
    Shukur HH; Hussain-Alkhateeb L; Farholt S; Nørregaard O; Jørgensen AP; Hoybye C
    J Clin Endocrinol Metab; 2021 Aug; 106(9):e3634-e3643. PubMed ID: 33950234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal evaluation of sleep-disordered breathing in children with Prader-Willi Syndrome during 2 years of growth hormone therapy.
    Al-Saleh S; Al-Naimi A; Hamilton J; Zweerink A; Iaboni A; Narang I
    J Pediatr; 2013 Feb; 162(2):263-8.e1. PubMed ID: 22947651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone treatment and adverse events in Prader-Willi syndrome: data from KIGS (the Pfizer International Growth Database).
    Craig ME; Cowell CT; Larsson P; Zipf WB; Reiter EO; Albertsson Wikland K; Ranke MB; Price DA;
    Clin Endocrinol (Oxf); 2006 Aug; 65(2):178-85. PubMed ID: 16886957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sleep cycling alternating pattern (CAP) expression is associated with hypersomnia and GH secretory pattern in Prader-Willi syndrome.
    Priano L; Grugni G; Miscio G; Guastamacchia G; Toffolet L; Sartorio A; Mauro A
    Sleep Med; 2006 Dec; 7(8):627-33. PubMed ID: 17023209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adiponectin levels in prepubertal children with Prader-Willi syndrome before and during growth hormone therapy.
    Festen DA; van Toorenenbergen A; Duivenvoorden HJ; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2007 Apr; 92(4):1549-54. PubMed ID: 17264186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between central adrenal insufficiency and sleep-related breathing disorders in children with Prader-Willi syndrome.
    de Lind van Wijngaarden RF; Joosten KF; van den Berg S; Otten BJ; de Jong FH; Sweep CG; de Weerd AW; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2009 Jul; 94(7):2387-93. PubMed ID: 19383777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone therapy and respiratory disorders: long-term follow-up in PWS children.
    Berini J; Spica Russotto V; Castelnuovo P; Di Candia S; Gargantini L; Grugni G; Iughetti L; Nespoli L; Nosetti L; Padoan G; Pilotta A; Trifirò G; Chiumello G; Salvatoni A;
    J Clin Endocrinol Metab; 2013 Sep; 98(9):E1516-23. PubMed ID: 23894156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized controlled GH trial: effects on anthropometry, body composition and body proportions in a large group of children with Prader-Willi syndrome.
    Festen DA; de Lind van Wijngaarden R; van Eekelen M; Otten BJ; Wit JM; Duivenvoorden HJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2008 Sep; 69(3):443-51. PubMed ID: 18363884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sleep-disordered breathing in Australian children with Prader-Willi syndrome following initiation of growth hormone therapy.
    Caudri D; Nixon GM; Nielsen A; Mai L; Hafekost CR; Kapur N; Seton C; Tai A; Blecher G; Ambler G; Bergman PB; Vora KA; Crock P; Verge CF; Tham E; Musthaffa Y; Lafferty AR; Jacoby P; Wilson AC; Downs J; Choong CS
    J Paediatr Child Health; 2022 Feb; 58(2):248-255. PubMed ID: 34397126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated insulin-like growth factor-I values in children with Prader-Willi syndrome compared with growth hormone (GH) deficiency children over two years of GH treatment.
    Feigerlová E; Diene G; Oliver I; Gennero I; Salles JP; Arnaud C; Tauber M
    J Clin Endocrinol Metab; 2010 Oct; 95(10):4600-8. PubMed ID: 20926543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prader-Willi syndrome: who can have growth hormone?
    Stafler P; Wallis C
    Arch Dis Child; 2008 Apr; 93(4):341-5. PubMed ID: 18089632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone mineral density in children and adolescents with Prader-Willi syndrome: a longitudinal study during puberty and 9 years of growth hormone treatment.
    Bakker NE; Kuppens RJ; Siemensma EP; Tummers-de Lind van Wijngaarden RF; Festen DA; Bindels-de Heus GC; Bocca G; Haring DA; Hoorweg-Nijman JJ; Houdijk EC; Jira PE; Lunshof L; Odink RJ; Oostdijk W; Rotteveel J; Van Alfen AA; Van Leeuwen M; Van Wieringen H; Wegdam-den Boer ME; Zwaveling-Soonawala N; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1609-18. PubMed ID: 25668198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study.
    Whitman BY; Myers S; Carrel A; Allen D
    Pediatrics; 2002 Feb; 109(2):E35. PubMed ID: 11826245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of adenotonsillectomy in patients with Prader-Willi syndrome.
    Meyer SL; Splaingard M; Repaske DR; Zipf W; Atkins J; Jatana K
    Arch Otolaryngol Head Neck Surg; 2012 Nov; 138(11):1047-51. PubMed ID: 23165379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone mineral density and effects of growth hormone treatment in prepubertal children with Prader-Willi syndrome: a randomized controlled trial.
    de Lind van Wijngaarden RF; Festen DA; Otten BJ; van Mil EG; Rotteveel J; Odink RJ; van Leeuwen M; Haring DA; Bocca G; Mieke Houdijk EC; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2009 Oct; 94(10):3763-71. PubMed ID: 19622627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of Sleep-Disordered Breathing in Prader-Willi Syndrome.
    Abushahin A; Al-Naimi A; Abu-Hasan M; Arar R; Lina Hayati M; Belavendra A; Janahi IA
    Can Respir J; 2023; 2023():9992668. PubMed ID: 37927914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sleep-Disordered Breathing in Children with Prader-Willi Syndrome in Relation to Growth Hormone Therapy Onset.
    Zimmermann M; Laemmer C; Woelfle J; Fimmers R; Gohlke B
    Horm Res Paediatr; 2020; 93(2):85-93. PubMed ID: 32535587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of NREM sleep in children with Prader-Willi syndrome and the effect of growth hormone treatment.
    Verrillo E; Bruni O; Franco P; Ferri R; Thiriez G; Pavone M; Petrone A; Paglietti MG; Crinò A; Cutrera R
    Sleep Med; 2009 Jun; 10(6):646-50. PubMed ID: 19027358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.